Published 13 May 2020
Introduction
In recent weeks, at least seven class action lawsuits have
been filed in federal district courts throughout the United
States against the government of the People's Republic of China
(the "P.R.C." or "China"), all relating to China's alleged
liability for damages and injuries sustained in the ongoing
COVID-19 pandemic. Although plaintiffs in these lawsuits make
broadly different claims, they all face the same highly
formidable legal roadblock: a need to find exceptions that can
pierce the presumptive immunity afforded to China and other
sovereign nations under the Foreign Sovereign Immunities Act
("FSIA"), 28 U.S.C. § 1602, et seq., which would
otherwise preclude their claims at the outset for lack of
jurisdiction.
To read this article you need to be a subscriber
Subscribe
Fill in the registration form and answer a few simple questions to receive a quote.
Subscribe now
Suggested Citation
M. Diaz, Jr.; M. Colomar-Garcia; B.C. Hadaway; G.E. Davidson; X.J. Zhao; J. Coronado; Z. Pan (2020, forthcoming) "The Façade of COVID-19 Class Action Litigation Against China Under the Foreign Sovereign Immunities Act"
(TDM, ISSN 1875-4120) May 2020, www.transnational-dispute-management.com
Other recently published material:
Summary of Young-OGEMID Hot Topic Discussion No. 2: "Empirical Study - Provisional Measures in Investor-State Arbitration" (February 2023)
24 August 2023
Counterclaims based on Corporate Climate Change Responsibility: Challenges and Prospects
22 August 2023
Simplifying the Pathway to 2030: The Need for More, not Less, Protection for Climate Change-Related investment
21 August 2023
Politics of Investment Protection: Is the Trend of Adopting Environmental Protection Clauses Bringing any Balance?
17 August 2023
How Are Investment Tribunals Going to Interpret 'Environmental Provisions' under New Generation Investment Agreements? - Mapping the Changes in Recent Treaties from 2016 to 2021
16 August 2023
Complete listing of Advance publication.